Toggle Offcanvas
...
 
Pibrentasvir Tenders

Pibrentasvir Tenders

View Pibrentasvir tenders, RFPs and contracts. Bid on readily available Pibrentasvir tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Pibrentasvir tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Pibrentasvir.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Pibrentasvir market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Pibrentasvir tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

4 Live Notices for Pibrentasvir Tenders

Showing 1 to 4

Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Glecaprevir | Pibrentasvir
country Germany
posting date22 Aug 2023
deadline11 Aug 2025
Conclusion Of Non-Exclusive Discount Agreements According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Glecaprevir | Pibrentasvir
country Germany
posting date21 Aug 2023
deadline11 Aug 2025
Conclusion Of A Non-Exclusive Discount Agreement According To § 130A Para. 8 Sgb V For The Active Substance Glecaprevir And Pibrentasvir, Atc J05Ap57 For The Period 09/01/2023 - 08/31/2025
country Germany
posting date21 Jul 2023
deadline05 Jul 2025
Medicines With The Active Substance Combination Glecaprevir And Pibrentasvir (Atc: J05Ap57)
country Germany
posting date19 May 2023
deadline30 Apr 2025

Share Share this page